B-Cure Laser

Diabetic Foot Ulcers - B-Cure Laser

Preliminary results from a double blind randomized placebo-control clinical study indicate that 12 weeks
 of daily B-Cure laser Pro treatments  significantly decrease wound size in patients with diabetic foot ulcers compared to sham irradiated controls.
 6 of 7 patients of the LLLT B-Cure Laser Pro group had >90% wound closure, whereas only 1 of 8 of the placebo group had this degree of reduction (p=0.01 by FET).

Exhibitor Data Sheet